Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression
Keyword(s):
Redox responsive epalrestat prodrug micelles facilitate synergistic concentrations of doxorubicin with an advantage of CD44 down-regulation and reduced cardiotoxicity.
Keyword(s):
Keyword(s):
1997 ◽
Vol 13
(6)
◽
pp. 517-528
◽
1991 ◽
Vol 14
(1)
◽
pp. 29-35
◽
Keyword(s):
2002 ◽
Vol 304
(3)
◽
pp. 1236-1242
◽
1992 ◽
Vol 215
(2-3)
◽
pp. 289-291
◽